SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-050823
Filing Date
2021-02-22
Accepted
2021-02-22 16:36:30
Documents
18
Period of Report
2021-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101114d8k.htm   iXBRL 8-K 32714
2 EX-1.1 d101114dex11.htm EX-1.1 221777
3 EX-5.1 d101114dex51.htm EX-5.1 10398
4 EX-99.1 d101114dex991.htm EX-99.1 8216
5 EX-99.2 d101114dex992.htm EX-99.2 8491
9 GRAPHIC g101114g0221005642814.jpg GRAPHIC 2771
10 GRAPHIC g101114g73z44.jpg GRAPHIC 2144
  Complete submission text file 0001193125-21-050823.txt   486110

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mtem-20210217.xsd EX-101.SCH 3057
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20210217_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20210217_pre.xml EX-101.PRE 11399
11 EXTRACTED XBRL INSTANCE DOCUMENT d101114d8k_htm.xml XML 3397
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 21660857
SIC: 2834 Pharmaceutical Preparations